Back to search

Ireland· IE-PA-EU/1/01/177/002

SonoVue 8 microlitres/mL powder and solvent for dispersion for injection

A schwefelhexafluorid, phospholipid-mikrosphären product containing sulphur hexafluoride, registered in Ireland by Bracco International B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC V08DA05

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedSonoVue 8 microlitres/mL powder and s…ATCV08DA05REGISTER NO.IE-PA-EU/1/01/177/002PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Schwefelhexafluorid, phospholipid-mikrosphären is registered in 11 of 19 countries.

Countries holding a registration under ATC V08DA05 (schwefelhexafluorid, phospholipid-mikrosphären), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Schwefelhexafluorid, phospholipid-mikrosphären · ATC V08DA05

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Sulphur hexafluoride
Manufacturer
Bracco International B.V.
Country
Ireland (IE)
ATC code
V08DA05
ATC class
Schwefelhexafluorid, Phospholipid-Mikrosphären
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/01/177/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f786d7f0-1f45-4ac4-bc1a-6d15f6373ec0
GET /v1/drugs/f786d7f0-1f45-4ac4-bc1a-6d15f6373ec0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "V08DA",
    "V08DA05"
  ],
  "strength": null,
  "pa_number": "EU/1/01/177/002",
  "substances": [
    "Sulphur hexafluoride"
  ],
  "legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "26/03/2001",
  "dispensing_status": "Product subject to Restricted Prescription (C)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about schwefelhexafluorid, phospholipid-mikrosphären.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.